Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure.
JAMA. 2011 May 25;305(20):2088-95
Authors: Alehagen U, Dahlström U, Rehfeld JF, Goetze JP
Measurement of plasma concentrations of the biomarker copeptin may help identify patients with heart failure at high and low risk of mortality, although the value of copeptin measurement in elderly patients is not fully known.
PMID: 21610241 [PubMed - in process]